PNW vs PPCB · P/E 19, rev $5.12B vs P/E 0.0, $3.9M cap
Pinnacle West Capital Corp (PNW) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported PNW revenue for 2024-12-31 was $5.12B. Net income was $626.0M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
PPCB does not have a complete income-statement cache yet.
PNW currently screens at market cap $12.41B and trailing P/E 19.1. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the PNW and PPCB stock pages for the full models.
Not investment advice.